Ann Surg

1. GANGARAM PANDAY SSG, Oudijk L, Lagarde SM, Mostert B, et al
   Local Regrowth After Neoadjuvant Chemoradiotherapy and Active Surveillance for Esophageal Cancer: An Analysis of Surgical Specimens From the SANO Trial.
   Ann Surg. 2026 Aug 21. doi: 10.1097/SLA.0000000000007179.
   

   >> Share

   
   

   
   BMC Cancer

2. WU CY, Chung MH
   Factors associated with readmission following reconstruction in head and neck skin cancer: a national readmission database analysis.
   BMC Cancer. 2026 Jun 13. doi: 10.1186/s12885-026-16350.
   

   >> Share

   
   
3. CARDIN GB, Pellerin-Viger A, Bernard M, Kessai F, et al
   Genome-wide association study of never-smoking non-drinking young adults developing oral squamous cell carcinoma.
   BMC Cancer. 2026;26:993.
   

   >> Share

   
   

   
   BMC Surg

4. JIN X, Xu Z, Wen L, Chen X, et al
   Does exposing all parathyroids during total thyroidectomy with central lymph node dissection protect long-term function? A prospective cohort study.
   BMC Surg. 2026 Jun 13. doi: 10.1186/s12893-026-03923.
   

   >> Share

   
   

   
   Br J Cancer

5. CHEN YW, Shiah SG, Yuan SS, Wang YY, et al
   A saliva-based surrogate associates with clinical outcome of oral potentially malignant disorders.
   Br J Cancer. 2026;135:818-829.
   

   >> Share

   
   
6. CHEN S, Wu Y, Rao G, Tong W, et al
   CD39(+)CD103(+)CD8(+) T cells enhance neoadjuvant chemoimmunotherapy efficacy in head and neck squamous cell carcinoma.
   Br J Cancer. 2026 Aug 20. doi: 10.1038/s41416-026-03588.
   

   >> Share

   
   

   
   Br J Oral Maxillofac Surg

7. SHEIKH O, Sundar S, Wingfield L, Mair M, et al
   Current concepts in scapular free flap reconstruction.
   Br J Oral Maxillofac Surg. 2026;64:530-545.
   

   >> Share

   
   
8. BURRIDGE I, Marwat M, Manoharan V, Abdi M, et al
   Selective deep lobe parotidectomy: a systematic review and meta-analysis of outcomes.
   Br J Oral Maxillofac Surg. 2026;64:555-564.
   

   >> Share

   
   

   
   Cancer

9. OYENUGA M, Goyal S, Hannan LM, Emiloju O, et al
   Analysis of real-world clinical outcomes of perioperative chemotherapy compared to preoperative chemoradiotherapy in esophagogastric adenocarcinoma.
   Cancer. 2026;132:e70571.
   

   >> Share

   
   

   
   Clin Cancer Res

10. RHOADES J, Patel A, Xiong K, Blewett T, et al
    Ultrasensitive circulating tumor DNA analysis improves detection of molecular residual disease in locally advanced esophageal cancer.
    Clin Cancer Res. 2026 Aug 21. doi: 10.1158/1078-0432.CCR-25-4852.
    

    >> Share

    
    
11. SABA NF, Posner M, Harrington K, Neupane P, et al
    Danvatirsen plus pembrolizumab versus pembrolizumab for recurrent and/or metastatic head and neck squamous cell carcinoma (PEMDA-HN): a randomized, phase 2 trial.
    Clin Cancer Res. 2026 Aug 19. doi: 10.1158/1078-0432.CCR-26-0819.
    

    >> Share

    
    

    
    Clin Nucl Med

12. YERDES E, Okuyan M, Elboga U
    Multiple Radioiodine-avid Skin Metastases From Thyroid Carcinoma Detected on Posttherapy 131I SPECT/CT.
    Clin Nucl Med. 2026 Aug 12. doi: 10.1097/RLU.0000000000006654.
    

    >> Share

    
    

    
    Dis Esophagus

13. SILVER A, Habib H, Giet L, Gossage J, et al
    Crural hiatoplasty with left liver buttress reinforcement for paraconduit hiatus hernia repair: early lessons from a single-center case series.
    Dis Esophagus. 2026;39:doag091.
    

    >> Share

    
    

    
    Int J Cancer

14. ABLINGER C, Huber-Cantonati P, Weber DD, Pichler S, et al
    Combination of Lenvatinib and Antibiotics: A Potential Approach to Enhance Sensitivity in Differentiated Thyroid Cancer.
    Int J Cancer. 2026;159:1974-1989.
    

    >> Share

    
    

    
    Int J Pediatr Otorhinolaryngol

15. WANG W, Zhang J
    Transoral excision of pediatric submandibular gland pleomorphic adenoma: A single-center case series.
    Int J Pediatr Otorhinolaryngol. 2026;208:112953.
    

    >> Share

    
    

    
    Int J Radiat Oncol Biol Phys

16. CHEN J, Liu Z, Yang Y, Muller OM, et al
    Causal Machine Learning Analysis of Empirical Relative Biological Effectiveness (RBE) for Mandible Osteoradionecrosis in Head and Neck Cancer Radiotherapy.
    Int J Radiat Oncol Biol Phys. 2026 Aug 20:S0360-3016(26)04201.
    

    >> Share

    
    
17. DU J, Huang Q, Wang W, Sheng Y, et al
    Association Between Linear Energy Transfer Distribution and Local Recurrence in Recurrent Nasopharyngeal Carcinoma Reirradiated With Intensity-Modulated Carbon Ion Therapy.
    Int J Radiat Oncol Biol Phys. 2026 Aug 18:S0360-3016(26)04072.
    

    >> Share

    
    

    
    J Clin Oncol

18. BURTNESS B, Rosenberg AJ, Calderon B, Lim SM, et al
    Amivantamab in Recurrent/Metastatic Head and Neck Squamous Cell Cancer After Checkpoint Inhibitor and Chemotherapy: Pivotal Results From the Phase Ib/II OrigAMI-4 Study.
    J Clin Oncol. 2026;44:2271-2277.
    

    >> Share

    
    

    
    Laryngoscope

19. YANG WY, Sattar Z, Sarathi CIP, Wadood A, et al
    One-Stop Throat and Virtual Neck Lump Clinic Shortens Diagnostic Work-Up for Head and Neck Cancer.
    Laryngoscope. 2026 Aug 18. doi: 10.1002/lary.70844.
    

    >> Share

    
    
20. NEWMAN K, Neevel A, Hess H, Tiner M, et al
    Identifying Velopharyngeal Dysfunction in Head and Neck Cancer Patients.
    Laryngoscope. 2026 Aug 18. doi: 10.1002/lary.70792.
    

    >> Share

    
    
21. NAGANO H, Kiyama S, Kyutoku T, Yamashita M, et al
    Genetic Mutations in Recurrent/Metastatic Papillary Thyroid Carcinoma.
    Laryngoscope. 2026 Aug 17. doi: 10.1002/lary.70842.
    

    >> Share

    
    

    
    Oral Oncol

22. CLATOT F, Vozy A, Dominiak G, Luciani L, et al
    Real-world treatment sequences and outcomes in recurrent/metastatic head and neck squamous cell carcinoma in France (TERENCE study).
    Oral Oncol. 2026;181:108106.
    

    >> Share

    
    

    
    Otolaryngol Head Neck Surg

23. KANE AC, Patel R, Kiparizoska E, Myatt GD, et al
    Structural Racism and Head and Neck Cancer Risks and Outcomes: A Scoping Review.
    Otolaryngol Head Neck Surg. 2026 Aug 17. doi: 10.1002/ohn.70374.
    

    >> Share

    
    

    
    PLoS One

24. MAYURASAKORN S, Somboonporn C, Theerakulpisut D
    The effects of stimulated thyroglobulin/ thyroid-stimulating hormone ratio and N1b status on the efficacy of the first I-131 treatment in patients with differentiated thyroid cancer.
    PLoS One. 2026;21:e0349850.
    

    >> Share

    
    

    
    Proc Natl Acad Sci U S A

25. SHINN CK, Saddawi-Konefka R, Salanga CL, Schokrpur S, et al
    Exploiting the CXCR3/CXCL10 axis overrides tumor immune suppression by enhancing immune trafficking and effector cell priming in HNSCC.
    Proc Natl Acad Sci U S A. 2026;123:e2522360123.
    

    >> Share

    
    
26. WANG X, Zhou Y, Tan J, Zhang D, et al
    USP14 competitively binds to FBXW7 to stabilize MTDH and promotes metastasis and drug resistance of head and neck squamous cell carcinoma.
    Proc Natl Acad Sci U S A. 2026;123:e2504068123.
    

    >> Share

    
    

    
    Radiother Oncol

27. NIELSEN CP, Huet-Dastarac M, Jensen K, Brink C, et al
    Multi-centre generalisability of deep learning-based dose prediction for head and neck radiotherapy using DAHANCA real-world data.
    Radiother Oncol. 2026;222:111702.
    

    >> Share

    
    
28. CACICEDO J, Hoyo OD, Canon V
    GTV Expert Opinion: Pushing the limits in re-irradiation in head and neck cancer: challenges, strategies and safety.
    Radiother Oncol. 2026;222:111581.
    

    >> Share

    
    
29. HE Q, Li Y, Long J, Luo X, et al
    Induction TPF versus adjuvant PF after CCRT in locally advanced nasopharyngeal carcinoma: A multicenter, randomized controlled phase III clinical trial.
    Radiother Oncol. 2026;223:111746.
    

    >> Share

    
    
30. HOL MLF, Suttie M, Gaze MN, Wiersma J, et al
    Dose-effect analysis of facial bone morphology following radiation therapy for head and neck rhabdomyosarcoma.
    Radiother Oncol. 2026;222:111492.
    

    >> Share

    
    
31. PARK SG, Yang E, Nam H, Kim TG, et al
    Tumor volume reduction during adaptive radiotherapy is a strong prognostic factor for oropharyngeal cancer: A retrospective multicenter study.
    Radiother Oncol. 2026;222:111676.
    

    >> Share

    
    
32. NAKAMURA S, Kodaira T, Machida R, Nakashima T, et al
    Definitive IMRT alone with reduced prophylactic nodal irradiation for Early-Stage Oropharyngeal Cancer: JCOG1208.
    Radiother Oncol. 2026;222:111677.
    

    >> Share

    
    
33. SIMOES R, van der Velden S, Gooding MJ, Boukerroui D, et al
    Variability in manual editing of head and neck organs of interest auto-segmentations: a multi-user, longitudinal analysis.
    Radiother Oncol. 2026;222:111684.
    

    >> Share

    
    
34. CARLWIG K, Jarl J, Nilsson P, Rasmusson E, et al
    Quality of life and cost-effectiveness of preoperative accelerated versus postoperative conventional radiotherapy for oral cavity cancer: Results from the randomised ARTSCAN 2 trial.
    Radiother Oncol. 2026;222:111688.
    

    >> Share

    
    
35. LIN J, Xu Z, Lu Y, Zhang Z, et al
    CT number-preserving bidirectional cycle GAN for contrast addition and removal in head-and-neck radiotherapy planning CT: A multicenter retrospective cohort study.
    Radiother Oncol. 2026;222:111691.
    

    >> Share

    
    
36. QIU Z, Bobic M, Kurtz J, Ajdari A, et al
    Time series analysis for optimal offline replanning timing in head and neck proton therapy.
    Radiother Oncol. 2026;222:111690.
    

    >> Share

    
    
37. CATALANO A, Materne S, Badenchini F, Gioscio E, et al
    Microvascular health status as a novel predictor of acute side effects after radiotherapy: a quantitative analysis across three cancer sites.
    Radiother Oncol. 2026;222:111693.
    

    >> Share

    
    
38. CHATTERJEE S, Maulik S, Sharma J, Khanum H, et al
    Results of intensifying radiation treatment in advanced laryngeal, hypopharyngeal (LH) and oropharyngeal cancers (OPC) using metabolic dose escalation strategies: (INTELHOPE).
    Radiother Oncol. 2026;222:111698.
    

    >> Share

    
    
39. KAUFMANN J, Nikolaidou E, Krabbes I, Oji N, et al
    Medial retropharyngeal lymph node involvement in nasopharyngeal cancer patients treated with radiotherapy in Germany - A multicenter analysis.
    Radiother Oncol. 2026;222:111696.
    

    >> Share

    
    
40. ZHU R, Zhang Y, Wang F, Pan C, et al
    Improved risk stratification for oral tongue squamous cell carcinoma using deep learning-based MRI classifier and pathological markers to guide postoperative radiotherapy: A multicenter cohort study.
    Radiother Oncol. 2026;222:111700.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share